Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- Drug Discovery Services Market worth US$27.23 billion in 2030 with 10.7% CAGR | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform [Yahoo! Finance]Yahoo! Finance
- Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery PlatformBusiness Wire
- Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $170.00 price target on the stock, down previously from $19MarketBeat
- 3 Reasons CRL is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
CRL
Earnings
- 2/19/25 - Beat
CRL
Sec Filings
- 2/26/25 - Form 4
- 2/21/25 - Form 4
- 2/21/25 - Form 4
- CRL's page on the SEC website